AJR Join ARRS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leslie, D. F.
Right arrow Articles by Harmsen, W. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leslie, D. F.
Right arrow Articles by Harmsen, W. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

American Journal of Roentgenology, Vol 165, 1403-1406, Copyright © 1995 by American Roentgen Ray Society


ARTICLES

Single-pass CT of hepatic tumors: value of globular enhancement in distinguishing hemangiomas from hypervascular metastases

DF Leslie, CD Johnson, RL MacCarty, EM Ward, DM Ilstrup and WS Harmsen
Department of Diagnostic Radiology, Mayo Clinic, Rochester, MN 55905, USA.

OBJECTIVE. The purpose of this study was to evaluate the sensitivity and specificity of globular enhancement for differentiating hepatic hemangiomas from hypervascular metastases on single-pass, contrast- enhanced CT scans. Globular enhancement was defined as enhancing nodules less than 1 cm seen within a lesion. MATERIALS AND METHODS. Fifty CT examinations were retrospectively evaluated in a blinded fashion by two independent reviewers. The CT studies were done with nonhelical technique after the IV injection of 150 ml of contrast material. The series included 25 patients with histologically proven hypervascular hepatic metastases (carcinoid, islet cell carcinoma, and leiomyosarcoma) and 25 patients with clinically proven hepatic hemangiomas. Patients with hemangiomas were clinically stable for at least 2 years after the CT studies. A single lesion was isolated from the first-pass, contrast-enhanced portion of each examination; the remainder of the examination was excluded from the review to minimize reviewer bias. Each lesion was evaluated for (1) the presence or absence of globular enhancement (defined as enhancing nodules less than 1 cm seen within a lesion), (2) the density of globular enhancement relative to that of the aorta, (3) the degree of border definition (well or poorly marginated), and (4) the presence or absence of a hypodense halo. A diagnostic impression was then recorded for each lesion. RESULTS. Globular enhancement was 88% sensitive and 84-100% specific for differentiating hepatic hemangiomas from hypervascular metastases (p < .001). A mean of 62% of hemangiomas showed globular enhancement isodense relative to that of the aorta; none of the metastases showed globular, isodense enhancement. The majority of the metastases showed nonglobular enhancement (mean, 92%). The reviewers showed 84% agreement in the identification of (1) globular enhancement in hemangiomas, (2) lack of globular enhancement in metastases, and (3) globular enhancement in the combined set of all lesions. Neither the presence of a hypodense halo nor the degree of border definition was significant in distinguishing between the two groups of lesions. The reviewers showed 96% agreement in the categorization of metastases and 76% agreement in the categorization of hemangiomas. There was 86% agreement in the categorization of all lesions. Overall, reviewers diagnosed a mean of 89% of lesions correctly. A mean of 98% of metastases and a mean of 80% of hemangiomas were diagnosed correctly. CONCLUSIONS. Globular enhancement is highly sensitive (88%) and specific (84-100%) for differentiating hepatic hemangiomas from hypervascular metastases on single-pass, contrast-enhanced CT scans.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
S. Goshima, M. Kanematsu, H. Kondo, R. Yokoyama, T. Miyoshi, H. Nishibori, H. Kato, H. Hoshi, M. Onozuka, and N. Moriyama
MDCT of the liver and hypervascular hepatocellular carcinomas: optimizing scan delays for bolus-tracking techniques of hepatic arterial and portal venous phases.
Am. J. Roentgenol., July 1, 2006; 187(1): W25 - W32.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
T. Kim, M. P. Federle, R. L. Baron, M. S. Peterson, and Y. Kawamori
Discrimination of Small Hepatic Hemangiomas from Hypervascular Malignant Tumors Smaller than 3 cm with Three-Phase Helical CT
Radiology, June 1, 2001; 219(3): 699 - 706.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
M.-G. Jeong, J.-S. Yu, and K. W. Kim
Hepatic Cavernous Hemangioma: Temporal Peritumoral Enhancement during Multiphase Dynamic MR Imaging
Radiology, September 1, 2000; 216(3): 692 - 697.
[Abstract] [Full Text]


Home page
Am. J. Roentgenol.Home page
G. T. Sica, H. Ji, and P. R. Ros
CT and MR Imaging of Hepatic Metastases
Am. J. Roentgenol., March 1, 2000; 174(3): 691 - 698.
[Full Text] [PDF]


Home page
RadiologyHome page
T. Ichikawa, M. P. Federle, L. Grazioli, and M. Nalesnik
Hepatocellular Adenoma: Multiphasic CT and Histopathologic Findings in 25 Patients
Radiology, March 1, 2000; 214(3): 861 - 868.
[Abstract] [Full Text]


Home page
RadioGraphicsHome page
V. Vilgrain, L. Boulos, M.-P. Vullierme, A. Denys, B. Terris, and Y. Menu
Imaging of Atypical Hemangiomas of the Liver with Pathologic Correlation
RadioGraphics, March 1, 2000; 20(2): 379 - 397.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Roentgen Ray Society.